Xtant Medical Holdings (XTNT) Misses Q3 EPS Views; Boosts FY16 Revenue Outlook

November 7, 2016 4:34 PM EST
Get Alerts XTNT Hot Sheet
Price: $0.66 +22.22%

Today's EPS Names:
MDLY, ODC, DTEA, More
Trade XTNT Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Xtant Medical Holdings (NYSE: XTNT) reported Q3 EPS of ($0.40), $0.32 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $23.1 million versus the consensus estimate of $22.1 million.

GUIDANCE:

Xtant Medical Holdings sees FY2016 revenue of $89-91 million, versus prior guidance of $87-90 million and the consensus of $88 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment